Skip to main content

and
Your search also matched 7 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Mild chronic hypoxia-induced HIF-2α interacts with c-MYC through competition with HIF-1α to induce hepatocellular carcinoma cell proliferation

Include preview-only content
  1. Article

    Open Access

    The functions and prognostic value of Krüppel‐like factors in breast cancer

    Krüppel‐like factors (KLFs) are zinc finger proteins which participate in transcriptional gene regulation. Although increasing evidence indicate that KLFs are involved in carcinogenesis and progression, its cl...

    Ke-Yun Zhu, Yao Tian, Ying-** Li, Qing-**ang Meng, Jie Ge in Cancer Cell International (2022)

  2. Article

    Open Access

    Distinct clinical and prognostic implication of IDH1/2 mutation and other most frequent mutations in large duct and small duct subtypes of intrahepatic cholangiocarcinoma

    Isocitrate dehydrogenase 1/2 (IDH1/2), BAP1, ARID1A and PBRM1 have been reported as the most frequent mutant genes in intrahepatic cholangiocarcinoma (ICC), and their relationships with clinicopathological fea...

    Bingqi Ma, Huijuan Meng, Ye Tian, Yingying Wang, Tianqiang Song, Ti Zhang in BMC Cancer (2020)

  3. Article

    Open Access

    Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a

    The original article [1] contains an error in Fig. 5a whereby the Western blot bands representing CyclinD1 have mistakenly been duplicated over the Western blot bands intended to represent SGK.

    Man-Qing Cao, A-Bin You, **ao-Dong Zhu, Wei Zhang in Journal of Hematology & Oncology (2018)

  4. Article

    Open Access

    miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a

    High frequency of recurrence is the major cause of the poor outcomes for patients with hepatocellular carcinoma (HCC). microRNA (miR)-182-5p emerged as a high-priority miRNA in HCC and was found to be related ...

    Man-Qing Cao, A-Bin You, **ao-Dong Zhu, Wei Zhang in Journal of Hematology & Oncology (2018)

  5. Article

    Open Access

    Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models

    Sorafenib is recognized as a standard treatment for advanced hepatocellular carcinoma (HCC). However, many patients have to adopt dose reduction or terminate the use of sorafenib because of side effects. In ad...

    Abin You, Manqing Cao, Zhigui Guo, Bingfeng Zuo in Journal of Hematology & Oncology (2016)